This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

#DigitalSkeptic: The Small Machine Miracle Near 34th Street

Tooling up the small machine
Investors should understand this small machine movement is still very early stage. Tomorrow Lab is -- at best -- prototyping primitive plastic parts. It will be some time before something like an iPhone comes out of this office. But at least based on several interviews with DiPietro and two Tomorrow Lab staffers, Shelby Thompson and Haiman Yie, the company has been getting exciting results with one of the most intriguing new devices in the small machine orbit -- the Benchtop Injection Molding Machine ($2,850) built by Woodbridge, Va.-based Medium Machinery.

What Tomorrow Lab's early work shows is benchtop injection molders do exactly that: A 3-foot-high, benchtop system can really inject fluid versions of viscous material -- usually warm plastics -- into a mold. Than that material is carefully allowed to cool into a tightly engineered shape, when it is released from that mold and sent on for other processing or final assembly. The injection-molded parts cost literally pennies per item to make and are the heart of everything from yes, the Apple iPhone to the Chevy Impala.

"Plastic parts are in 90% of products," said Levon Fiore, owner and founder of Medium Machinery. "The idea of this machine was to offer as near-professional quality in a device that most any maker making any sort of product could afford."

Investors should also note that for all the upside of small machines such as the Benchtop Injection Molding Machine, limitations have emerged. For starters, documentation for a device this complex turned out to be a challenge. "We opened the box and found that the photos did not exactly match the product in the box," Thompson said. "We eventually figured it out. But unless you have experience in these tools that could have been difficult."

Next, a benchtop injection molder is like any tool. It's not a free-standing machine. It requires a certain level of infrastructure to work properly -- in this case an air compressor was needed to provide the heat and pressure to inject plastics into molds. "It was not a big thing for an office like ours to invest in that system," said Tomorrow Lab's Ullrich. "But still, it's a step that would need to be taken, and it costs real money."

Finally, there was the major issue of testing. Tomorrow Lab estimates that roughly three-quarters of the 20 or so hours it took to get the device working was spent on trial-and-error testing. Meaning expertise will be key in getting good -- and profitable -- results.

"I think that the amount of testing time they saw was a little high. We have never had a complaint from the hundreds of machines we have sold," said Medium Machinery's Fiore. "But as these tools go into wider circulation, I can see all these challenges beings ones we need to address."

Machining some small machine upside
In spite of the issues, Tomorrow Labs' testing into the tomorrow of making things is clearly cause for investor glee. Not only will this family of small machines speed the recovery of domestic U.S. manufacturing, but small machine assembly plants like the prototype system here will be snug and slick enough to add real value to really unlikely places -- including smack in the middle of some of the most expensive real estate on earth: right here, just five blocks from the Empire State Building.

"I did not want to make something that would sit on a shelf and get Christmas decorations put on it," Fiore said. "I wanted a useful tool that could make useful things."

Fiore -- and small machine makers like him -- have given investors the greatest holiday gift of all in 2013: hope.

This commentary comes from an independent investor or market observer as part of TheStreet guest contributor program. The views expressed are those of the author and do not necessarily represent the views of TheStreet or its management.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
AAPL $123.25 0.00%
FB $83.30 0.00%
GOOG $548.34 0.00%
TSLA $185.00 0.00%
YHOO $45.10 0.00%

Markets

DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs